Otsuka Pharmaceutical Co Ltd
1 products tracked · names used in filings: Otsuka Pharmaceutical Co Ltd
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 24 Jul 2026🇺🇸 FDA approval
FDA approves Simtriyo (centanafadine hydrochloride), a new medicine
Otsuka Pharmaceutical Co Ltd; NDA218145; New molecular entity, Priority review; capsule, extended release · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Simtriyo centanafadine hydrochloride | Approved | 2026-07-24 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.